On the other hand, in patients with recent onset SCH, L-T4 replacement therapy could decrease serum UA levels by improving insulin sensitivity, indicating the influential role of thyroid hormones for modulating UA metabolism (9). The gene discussed is INS; the disease is spindle cell hemangioma.